Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NONPEPTIDE ANTAGONIST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 393 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hyman, AL; De Witt, BJ; Gumusel, B; Hao, QZ; Kadowitz, PJ; Lippton, HL
      L-NAME enhances responses to atrial natriuretic peptide in the pulmonary vascular bed of the cat

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Heinrichs, SC; Tache, Y
      Therapeutic potential of CRF receptor antagonists: a gut-brain perspective

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. Rogers, DF
      Tachykinin receptor antagonists for asthma and COPD

      EXPERT OPINION ON THERAPEUTIC PATENTS
    4. Rasmussen, TN; Schmidt, P; Poulsen, SS; Holst, JJ
      Effect of calcitonin gene-related peptide (CGRP) on motility and on the release of substance P, neurokinin A, somatostatin and gastrin in the isolated perfused porcine antrum

      NEUROGASTROENTEROLOGY AND MOTILITY
    5. Amadesi, S; Moreau, J; Tognetto, M; Springer, J; Trevisani, M; Naline, E; Advenier, C; Fisher, A; Vinci, D; Mapp, C; Miotto, D; Cavallesco, G; Geppetti, P
      NK1 receptor stimulation causes contraction and inositol phosphate increase in medium-size human isolated bronchi

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    6. Dziadulewicz, EK; Walpole, CS; Snell, CR; Wrigglesworth, R; Hughes, GA; Beattie, D; Wood, JN; Beech, MM; Coote, PR
      Design of non-peptide CCK2 and NK1 peptidomimetics using 1-(2-nitrophenyl)thiosemicarbazide as a novel common scaffold

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    7. O'Brien, D; Skelton, KH; Owens, MJJ; Nemeroff, CB
      Are CRF receptor antagonists potential antidepressants?

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    8. Cirillo, R; Astolfi, M; Conte, B; Lopez, G; Parlani, M; Sacco, G; Terracciano, R; Fincham, CI; Sisto, A; Evangelista, S; Maggi, CA; Manzini, S
      Pharmacology of MEN 11467: a potent new selective and orally-effective peptidomimetic tachykinin NK1 receptor antagonist

      NEUROPEPTIDES
    9. Hennessy, MB; Pitstick, L; O'Leary, S; Maken, DS; Farre, AJ
      Effects of a novel potential antidepressant on the behavior and cortisol levels of isolated guinea pig pups

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    10. Kamijo, Y; Hayashi, I; Soma, K; Ohwada, T; Majima, M
      Effect of neutral endopeptidase inhibitor on bradykinin-induced bronchoconstriction

      LIFE SCIENCES
    11. Smith, BJ; Doran, AC; McLean, S; Tingly, FD; O'Neill, BT; Kajiji, SM
      P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    12. Rumsey, WL; Aharony, D; Bialecki, RA; Abbott, BM; Barthlow, HG; Caccese, R; Ghanekar, S; Lengel, D; McCarthy, M; Wenrich, B; Undem, B; Ohnmacht, C; Shenvi, A; Albert, JS; Brown, F; Bernstein, PR; Russell, K
      Pharmacological characterization of ZD6021: A novel, orally active antagonist of the tachykinin receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. Hegde, VR; Puar, MS; Dai, P; Pu, H; Patel, M; Anthes, JC; Richard, C; Terracciano, J; Das, PR; Gullo, V
      Family of depsi-peptide fungal metabolites, as selective and competitive human tachykinin receptor (NK2) antagonists: Fermentation, isolation, physico-chemical properties, and biological activity

      JOURNAL OF ANTIBIOTICS
    14. Giuliani, S; Guelfi, M; Toulouse, M; Bueno, L; Lecci, A; Tramontana, M; Criscuoli, M; Maggi, CA
      Effect of a tachykinin NK2 receptor antagonist, nepadutant, on cardiovascular and gastrointestinal function in rats and dogs

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Ballard, TM; Sanger, S; Higgins, GA
      Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist

      EUROPEAN JOURNAL OF PHARMACOLOGY
    16. Wong, LL; Verbalis, JG
      Vasopressin V2 receptor antagonists

      CARDIOVASCULAR RESEARCH
    17. Palm, C; Reimann, D; Gross, P
      The role of V2 vasopressin antagonists in hyponatremia

      CARDIOVASCULAR RESEARCH
    18. Roper, S; Frackenpohl, J; Schrake, O; Wartchow, R; Hoffmann, HMR
      Synthesis of enantiopure 1-azabicyclo[3.2.2]nonanes via stereoselective capture of chiral carbocations

      ORGANIC LETTERS
    19. Hay, DWP
      Chronic obstructive pulmonary disease: emerging therapies

      CURRENT OPINION IN CHEMICAL BIOLOGY
    20. Nakazato, A; Kumagai, T; Okubo, T; Tanaka, H; Chaki, S; Okuyama, S; Tomisawa, K
      Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor(1) receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY
    21. Lu, L; Ceng, XB; Huang, MS
      Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats

      NEUROREPORT
    22. Burrell, LM; Risvanis, J; Johnston, CI; Naitoh, M; Balding, LC
      Vasopressin receptor antagonism - a therapeutic option in heart failure and hypertension

      EXPERIMENTAL PHYSIOLOGY
    23. Naito, A; Ohtake, Y; Hasegawa, H; Fukaya, Y; Kurasawa, T; Naito, K; Matsukawa, H; Oguma, T; Ezure, Y; Tsuriya, Y; Tanaka, H; Koike, K; Shigenobu, K
      Pharmacological profile of VP-343, a novel selective vasopressin V-2 receptor antagonist, in rats

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    24. Goeders, NE; Guerin, GF
      Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats

      NEUROPSYCHOPHARMACOLOGY
    25. Schmidt, PT; Tornoe, K; Poulsen, SS; Rasmussen, TN; Holst, JJ
      Tachykinins in the porcine pancreas: Potent exocrine and endocrine effectsvia NK-1 receptors

      PANCREAS
    26. Gutman, DA; Owens, MJ; Nemeroff, CB
      Corticotropin-releasing factor antagonists as novel psychotherapeutics

      DRUGS OF THE FUTURE
    27. Campbell, EA; Gentry, C; Patel, S; Kidd, B; Cruwys, S; Fox, AJ; Urban, L
      Oral anti-hyperalgesic and anti-inflammatory activity of NK1 receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig

      PAIN
    28. Onori, L; Aggio, A; Taddei, G; Tonini, M
      Contribution of NK2 tachykinin receptors to propulsion in the rabbit distal colon

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    29. Lam, FFY
      Pharmacologic characterization of receptor types mediating coronary vasodilator actions of sensory neuropeptides in the guinea pig

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    30. Joos, GF; Germonpre, PF; Pauwels, RA
      Role of tachykinins in asthma

      ALLERGY
    31. Tanpo, T; Nabe, T; Yasui, K; Kamiki, T; Kohno, S
      Participation of neuropeptides in antigen-induced contraction of guinea pig bronchi via NK2 but not NK1 receptor stimulation

      PHARMACOLOGY
    32. Hokfelt, T; Broberger, C; Xu, ZQD; Sergeyev, V; Ubink, R; Diez, M
      Neuropeptides - an overview

      NEUROPHARMACOLOGY
    33. Rupniak, NMJ; Carlson, EC; Harrison, T; Oates, B; Seward, E; Owen, S; de Felipe, C; Hunt, S; Wheeldon, A
      Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice

      NEUROPHARMACOLOGY
    34. Houghton, AK; Ogilvie, J; Clarke, RW
      The involvement of tachykinin NK2 and NK3 receptors in central sensitization of a spinal withdrawal reflex in the decerebrated, spinalized rabbit

      NEUROPHARMACOLOGY
    35. Sarau, HM; Mooney, JL; Schmidt, DB; Foley, JJ; Buckley, PT; Giardina, GAM; Wang, DY; Lee, JA; Hay, DWP
      Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin

      MOLECULAR PHARMACOLOGY
    36. Palma, C; Maggi, CA
      The role of tachykinins via NK1 receptors in progression of human gliomas

      LIFE SCIENCES
    37. Zobel, AW; Nickel, T; Kunzel, HE; Ackl, N; Sonntag, A; Ising, M; Holsboer, F
      Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

      JOURNAL OF PSYCHIATRIC RESEARCH
    38. Valenza, S; Cordero, FM; Brandi, A; Guidi, A; Altamura, M; Giolitti, A; Giuntini, F; Pasqui, F; Renzetti, AR; Maggi, CA
      Regio- and stereoselective cycloadditions of cyclic nitrones to maleic diamide forced in a peptide: Synthesis of potent ligands of human NK-2 receptor

      JOURNAL OF ORGANIC CHEMISTRY
    39. Iredale, PA; Alvaro, JD; Lee, Y; Terwilliger, R; Chen, YL; Duman, RS
      Role of corticotropin-releasing factor receptor-1 in opiate withdrawal

      JOURNAL OF NEUROCHEMISTRY
    40. Pierson, ME; Comstock, JM; Simmons, PD; Julien, R; Kaiser, F; Rosamond, JD
      CCK peptides with combined features of hexa- and tetrapeptide CCK-A agonists

      JOURNAL OF MEDICINAL CHEMISTRY
    41. Barroso, S; Richard, F; Nicolas-Etheve, D; Reversat, JL; Bernassau, JM; Kitabgi, P; Labbe-Jullie, C
      Identification of residues involved in neurotensin binding and modeling ofthe agonist binding site in neurotensin receptor 1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. Moody, TW; Jensen, RT; Garcia, L; Leyton, J
      Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    43. Moreaux, B; Nemmar, A; Vincke, G; Halloy, D; Beerens, D; Advenier, C; Gustin, P
      Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs

      EUROPEAN JOURNAL OF PHARMACOLOGY
    44. Diemunsch, P; Grelot, L
      Potential of substance P antagonists as antiemetics

      DRUGS
    45. Kerr, KP; Thai, B; Coupar, IM
      Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK2 receptors

      BRITISH JOURNAL OF PHARMACOLOGY
    46. Fromy, B; Merzeau, S; Abraham, P; Saumet, JL
      Mechanisms of the cutaneous vasodilator response to local external pressure application in rats: involvement of CGRP, neurokinins, prostaglandins andNO

      BRITISH JOURNAL OF PHARMACOLOGY
    47. Mazzone, SB; Geraghty, DP
      Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    48. Naka, T
      Discovery of a new class of antihypertensive agents, nonpeptide angiotensin II receptor antagonists : Candesartan cilexetil

      NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY
    49. Le, AD; Harding, S; Juzytsch, W; Watchus, J; Shalev, U; Shaham, Y
      The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats

      PSYCHOPHARMACOLOGY
    50. McCarthy, JR; Heinrichs, SC; Grigoriadis, DE
      Recent advances with the CRF1 receptor: Design of small molecule inhibitors, receptor subtypes and clinical indications

      CURRENT PHARMACEUTICAL DESIGN
    51. Owens, MJ; Nemeroff, CB
      Corticotropin-releasing factor antagonists - Therapeutic potential in the treatment of affective disorders

      CNS DRUGS
    52. Okada, T; Hirayama, Y; Kishi, S; Miyayasu, K; Hiroi, J; Fujii, T
      Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells

      INFLAMMATION RESEARCH
    53. Greenfeder, S; Cheewatrakoolpong, B; Billah, M; Egan, RW; Keene, E; Murgolo, NJ; Anthes, JC
      The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differ

      BIOORGANIC & MEDICINAL CHEMISTRY
    54. Guillon, J; Dallemagne, P; Stiebing, S; Bovy, PR; Rault, S
      First synthesis of 1-phenyl-3-pyrrol-1-ylindan-2-carboxylic acid, a new scaffold of potential non-peptide endothelin receptor antagonists

      SYNLETT
    55. Ingenhoven, N; Beck-Sickinger, AG
      Molecular characterization of the ligand-receptor interaction of neuropeptide Y

      CURRENT MEDICINAL CHEMISTRY
    56. Singh, LK; Pang, XZ; Alexacos, N; Letourneau, R; Theoharides, TC
      Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders

      BRAIN BEHAVIOR AND IMMUNITY
    57. Fisher, L; Pennefather, JN
      Tachykinin receptors mediating contractions of oestrogen-primed rat uterus: Classification using non-peptide antagonists

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    58. Quinn, RJ
      High-throughput screening in natural product drug discovery in Australia utilising Australia's biodiversity

      DRUG DEVELOPMENT RESEARCH
    59. Sakurada, C; Watanabe, C; Inoue, M; Koichi, TN; Ando, R; Kisara, K; Sakurada, T
      Spinal actions of CR73632, a novel tachykinin NK1 receptor agonist

      PEPTIDES
    60. Thibonnier, M; Kilani, A; Rahman, M; DiBlasi, TP; Warner, K; Smith, MC; Leenhardt, AF; Brouard, R
      Effects of the nonpeptide V-1 vasopressin receptor antagonist SR49059 in hypertensive patients

      HYPERTENSION
    61. Riegler, M; Castagliuolo, I; So, PTC; Lotz, M; Wang, C; Wlk, M; Sogukoglu, T; Cosentini, E; Bischof, G; Hamilton, G; Teleky, B; Wenzl, E; Matthews, JB; Pothoulakis, C
      Effects of substance P on human colonic mucosa in vitro

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    62. Inoue, M; Yamada, T; Ueda, H
      Low dose of kyotorphin (tyrosine-arginine) induces nociceptive responses through a substance P release from nociceptor endings

      MOLECULAR BRAIN RESEARCH
    63. Schmidt, PT; Rickelt, LF; Holst, JJ
      Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors

      DIGESTIVE DISEASES AND SCIENCES
    64. Rizzo, CA; Valentine, AF; Egan, RW; Kreutner, W; Hey, JA
      NK2-receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle

      NEUROPEPTIDES
    65. Wagner, U; Fehmann, HC; Bredenbroker, D; Kluber, D; Lange, A; von Wichert, P
      Effects of selective tachykinin-receptor antagonists on tachykinin-inducedairway mucus secretion in the rat

      NEUROPEPTIDES
    66. Reed-Hagen, AE; Tsuchiya, M; Shimada, K; Wentland, JA; Obach, RS
      Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptorantagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites

      BIOPHARMACEUTICS & DRUG DISPOSITION
    67. Huskey, SEW; Luffer-Atlas, D; Dean, BJ; McGowan, EM; Feeney, WP; Chiu, SHL
      Substance P receptor antagonist I: Conversion of phosphoramidate prodrug after i.v. administration to rats and dogs

      DRUG METABOLISM AND DISPOSITION
    68. Alexacos, N; Pang, X; Boucher, W; Cochrane, DE; Sant, GR; Theoharides, TC
      Neurotensin mediates rat bladder mast cell degranulation triggered by acute psychological stress

      UROLOGY
    69. Hay, DWP; Barnette, MS
      Current and potential new therapies for chronic obstructive pulmonary disease

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34
    70. Altier, N; Stewart, J
      The tachykinin NK-1 receptor antagonist, RP-67580, infused into the ventral tegmental area prevents stress-induced analgesia in the formalin test

      PHYSIOLOGY & BEHAVIOR
    71. Huang, XP; Williams, FE; Peseckis, SM; Messer, WS
      Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M-1 muscarinic acetylcholine receptors

      MOLECULAR PHARMACOLOGY
    72. Couture, R; Toma, N; Barbot, L
      SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat

      LIFE SCIENCES
    73. Natsugari, H; Ikeura, Y; Kamo, I; Ishimaru, T; Ishichi, Y; Fujishima, U; Tanaka, T; Kasahara, F; Kawada, M; Doi, T
      Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK1 receptor antagonists: Synthesis, antagonistic activity, and effects on bladder functions

      JOURNAL OF MEDICINAL CHEMISTRY
    74. Castagliuolo, I; Wang, CC; Valenick, L; Pasha, A; Nikulasson, S; Carraway, RE; Pothoulakis, C
      Neurotensin is a proinflammatory neuropeptide in colonic inflammation

      JOURNAL OF CLINICAL INVESTIGATION
    75. Gigoux, V; Escrieut, C; Fehrentz, JA; Poirot, S; Maigret, B; Moroder, L; Gully, D; Martinez, J; Vaysse, N; Fourmy, D
      Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    76. Doi, T; Kamo, I; Imai, S; Okanishi, S; Ishimaru, T; Ikeura, Y; Natsugari, H
      Effects of TAK-637, a tachykinin receptor antagonist, on lower urinary tract function in the guinea pig

      EUROPEAN JOURNAL OF PHARMACOLOGY
    77. Gouldson, P; Legoux, P; Carillon, C; Delpech, B; Le Fur, G; Ferrara, P; Shire, D
      Contrasting roles of Leu(356) in the human CCK1 receptor for antagonist SR27897 and agonist SR 146131 binding

      EUROPEAN JOURNAL OF PHARMACOLOGY
    78. Rudd, JA; Ngan, MP; Wai, MK
      Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew)

      EUROPEAN JOURNAL OF PHARMACOLOGY
    79. Laszlo, FA; Varga, C; Nakamura, S
      Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage

      EUROPEAN JOURNAL OF PHARMACOLOGY
    80. Rupniak, NMJ; Kramer, MS
      Discovery of the anti-depressant and anti-emetic efficacy of substance P receptor (NK1) antagonists

      TRENDS IN PHARMACOLOGICAL SCIENCES
    81. CLARKE D; SOTHINATHAN R; SPETH RC; SANDBERG K
      BALANCED AFFINITY AT(1) AT(2) RECEPTOR NONPEPTIDE BINDING-SITE DETERMINANTS ON THE AT(1) ANGIOTENSIN RECEPTOR/

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    82. Vanderheyden, PML; Van Liefde, I; de Backer, JP; Vauquelin, G
      [H-3]-BIBP3226 and [H-3]-NPY binding to intact SK-N-MC cells and CHO cellsexpressing the human Y-1 receptor

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    83. DAOUI S; COGNON C; NALINE E; EMONDSALT X; ADVENIER C
      INVOLVEMENT OF TACHYKININ NK3 RECEPTORS IN CITRIC ACID-INDUCED COUGH AND BRONCHIAL RESPONSES IN GUINEA-PIGS

      American journal of respiratory and critical care medicine
    84. SHERWOOD JE; YOUNG S; SELIG W; SCHILLING A; KREUTNER W; EGAN RW; CHAPMAN RW
      A METHOD TO MEASURE DUAL NK1 NK2-ANTAGONIST ACTIVITY IN DOGS/

      Journal of pharmacological and toxicological methods
    85. MILLER LA; COCHRANE DE; FELDBERG RS; CARRAWAY RE
      INHIBITION OF NEUROTENSIN-STIMULATED MAST-CELL SECRETION AND CARBOXYPEPTIDASE-A ACTIVITY BY THE PEPTIDE INHIBITOR OF CARBOXYPEPTIDASE-A ANDNEUROTENSIN-RECEPTOR ANTAGONIST SR-48692

      International archives of allergy and immunology
    86. HARADAHIRA T; INOUE O; KOBAYASHI K; SUZUKI K
      SYNTHESIS AND EVALUATION OF C-11 LABELED NONPEPTIDE ANTAGONISTS FOR CHOLECYSTOKININ RECEPTORS - [C-11] L-365,260 AND [C-11] L-365,346

      Nuclear medicine and biology
    87. GREENFEDER S; CHEEWATRAKOOLPONG B; ANTHES J; BILLAH M; EGAN RW; BROWN JE; MURGOLO NJ
      2 RELATED NEUROKININ-1 RECEPTOR ANTAGONISTS HAVE OVERLAPPING BUT DIFFERENT BINDING-SITES

      Bioorganic & medicinal chemistry
    88. ROSEN TJ; COFFMAN KJ; MCLEAN S; CRAWFORD RT; BRYCE DK; GOHDA Y; TSUCHIYA M; NAGAHISA A; NAKANE M; LOWE JA
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF CP-122,721, A 2ND-GENERATION NK-1 RECEPTOR ANTAGONIST

      Bioorganic & medicinal chemistry letters
    89. Boichot, E; Germain, N; Emonds-Alt, X; Advenier, C; Lagente, V
      Effects of SR 140333 and SR 48968 on antigen and substance P-induced activation of guinea-pig alveolar macrophages

      CLINICAL AND EXPERIMENTAL ALLERGY
    90. KIM KH
      BUILDING A BRIDGE BETWEEN G-PROTEIN-COUPLED RECEPTOR MODELING, PROTEIN CRYSTALLOGRAPHY AND 3D QSAR STUDIES FOR LIGAND DESIGN

      Perspectives in drug discovery and design
    91. VANSCHOOR J; JOOS GF; CHASSON BL; BROUARD RJ; PAUWELS RA
      THE EFFECT OF THE NK2 TACHYKININ RECEPTOR ANTAGONIST SR-48968 (SAREDUTANT) ON NEUROKININ-A INDUCED BRONCHOCONSTRICTION IN ASTHMATICS

      The European respiratory journal
    92. LACOURCIERE Y; POOL JL; SVETKEY L; GRADMAN AH; LAROCHELLE P; DECHAMPLAIN J; SMITH WB
      A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER TRIAL OF 4 DOSES OF TASOSARTAN IN PATIENTS WITH ESSENTIAL-HYPERTENSION

      American journal of hypertension
    93. MCCARSON KE; KRAUSE JE; MCLEAN S
      CHRONIC NONPEPTIDE NEUROKININ RECEPTOR ANTAGONIST TREATMENT ALTERS STRIATAL TACHYKININ PEPTIDE AND RECEPTOR GENE-EXPRESSION IN THE RAT

      Neuroscience letters
    94. GINES P; BERL T; BERNARDI M; BICHET DG; HAMON G; JIMENEZ W; LIARD JF; MARTIN PY; SCHRIER RW
      HYPONATREMIA IN CIRRHOSIS - FROM PATHOGENESIS TO TREATMENT

      Hepatology
    95. GUILLON J; DALLEMAGNE P; PFEIFFER B; RENARD P; MANECHEZ D; KERVRAN A; RAULT S
      SYNTHESIS OF NEW PYRROLO[1,2-A]QUINOXALINES - POTENTIAL NONPEPTIDE GLUCAGON RECEPTOR ANTAGONISTS

      European journal of medicinal chemistry
    96. DIZ DI; WESTWOOD B; BOSCH SM; GANTEN D; FERRARIO C
      NK1 RECEPTOR ANTAGONIST BLOCKS ANGIOTENSIN-II RESPONSES IN RENIN TRANSGENIC RAT MEDULLA-OBLONGATA

      Hypertension
    97. SCHAEFFER P; LAPLACE MC; BERNAT A; PRABONNAUD V; GULLY D; LESPY L; HERBERT JM
      SR142948A IS A POTENT ANTAGONIST OF THE CARDIOVASCULAR EFFECTS OF NEUROTENSIN

      Journal of cardiovascular pharmacology
    98. KRAMER MS; CUTLER N; FEIGHNER J; SHRIVASTAVA R; CARMAN J; SRAMEK JJ; REINES SA; LIU GH; SNAVELY D; WYATTKNOWLES E; HALE JJ; MILLS SG; MACCOSS M; SWAIN CJ; HARRISON T; HILL RG; HEFTI F; SCOLNICK EM; CASCIERI MA; CHICCHI GG; SADOWSKI S; WILLIAMS AR; HEWSON L; SMITH D; CARLSON EJ; HARGREAVES RJ; RUPNIAK NMJ
      DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS

      Science
    99. HOLZER P; LIPPE IT; HEINEMANN A; BARTHO L
      TACHYKININ NK1 AND NK2 RECEPTOR-MEDIATED CONTROL OF PERISTALTIC PROPULSION IN THE GUINEA-PIG SMALL-INTESTINE IN-VITRO

      Neuropharmacology
    100. TAHARA A; SAITO M; SUGIMOTO T; TOMURA Y; WADA K; KUSAYAMA T; TSUKADA J; ISHII N; YATSU T; UCHIDA W; TANAKA A
      PHARMACOLOGICAL CHARACTERIZATION OF YMO87, A POTENT, NONPEPTIDE HUMANVASOPRESSIN V-1A AND V-2 RECEPTOR ANTAGONIST

      Naunyn-Schmiedeberg's archives of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 03:25:39